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Abstract
Epizootic shell disease (ESD) in the American lobster, Homarus americanus,
has a major impact on the southern New England lobster industry, yet there are no
practical tools for managing the disease. The goal of this study was to identify bacterial
probiotics that could be used to manage ESD in wild lobster populations. Candidate
bacterial isolates (n = 24) were previously isolated from lobsters in Narragansett Bay
and identified as having probiotic characteristics against ESD-associated bacteria
Thalassobius sp. and Aquimarina macrocephali, or the fish pathogen Vibrio
anguillarum. Healthy lobster post-larvae were exposed to five of the candidate strains
isolated from lobsters and a probiotic bacterial strain isolated from the Eastern oyster,
Crassostrea virginica (Phaeobacter inhibens S4). After several weeks of treatment,
there were no significant differences in molting frequency, mortality, or growth of
treated lobsters when compared with the control, indicating the candidate probiotics do
not adversely affect lobster post-larvae. The effect of selected candidate probiotics (n =
3) on progression of ESD in adult lobsters was tested for three months. Frequent molting
due to high disease severity confounded long-term effects of the treatments, and no
significant differences were seen in mortality, molting, growth, or disease progression.
These results highlight the challenges involved in the development of tools for the
management of a chronic disease with a poorly understood etiology. Future research
should focus on a better understanding of microbe-microbe-host interactions in ESD,
and the effect of environmental conditions on these interactions.
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CHAPTER I

Utilization of probiotics to manage epizootic shell disease in the
American lobster, Homarus americanus

Melissa Hoffman1*, Kathy Castro1, Grace Underwood2, Hilary Ranson3, Mitch
Hatzipetro1, Barbara Somers1, David Rowley3, David R. Nelson2, Marta GomezChiarri1
1

Department of Fisheries, Animal, and Veterinary Sciences, University of Rhode Island, Kingston, RI
Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI
3
Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI
2
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Abstract
Epizootic shell disease (ESD) in the American lobster, Homarus americanus,
has a major impact on the southern New England lobster industry, yet there are no
practical tools for managing the disease. The goal of this study was to identify bacterial
probiotics that could be used to manage ESD in wild lobster populations. Candidate
bacterial isolates (n = 24) were previously isolated from lobsters in Narragansett Bay
and identified as having probiotic characteristics against ESD-associated bacteria
Thalassobius sp. and Aquimarina macrocephali, or the fish pathogen Vibrio
anguillarum. Healthy lobster post-larvae were exposed to five of the candidate strains
isolated from lobsters and a probiotic bacterial strain isolated from the Eastern oyster,
Crassostrea virginica (Phaeobacter inhibens S4). After several weeks of treatment,
there were no significant differences in molting frequency, mortality, or growth of
treated lobsters when compared with the control, indicating the candidate probiotics do
not adversely affect lobster post-larvae. The effect of selected candidate probiotics (n =
3) on progression of ESD in adult lobsters was tested for three months. Frequent molting
due to high disease severity confounded long-term effects of the treatments, and no
significant differences were seen in mortality, molting, growth, or disease progression.
These results highlight the challenges involved in the development of tools for the
management of a chronic disease with a poorly understood etiology. Future research
should focus on a better understanding of microbe-microbe-host interactions in ESD,
and the effect of environmental conditions on these interactions.
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Introduction
Heavy economic and cultural dependence on American lobsters (Homarus
americanus) make coastal communities and stakeholders vulnerable in the face of
disease outbreak. In 2016, roughly 159 million pounds of lobster were harvested in the
U.S., worth nearly $670 million (NMFS 2018). Strong cultural ties with lobsters
encourage tourism, further increasing their economic importance (Steneck et al. 2011).
While southern New England makes up a small portion of this industry, this stock has
been the most susceptible to an emergent disease in lobsters, known as epizootic shell
disease (ESD).
In 1996, ESD was reported in lobsters in Rhode Island (Castro and Angell 2000).
Since this onset, annual lobster catches in Rhode Island have reduced significantly, with
annual landings falling in value from $19 million in the 1990’s to around $12 million in
2015 (NMFS 2016). It was estimated in 2012 that 10-30% of lobsters in Rhode Island
had ESD (Castro and Somers 2012). This proportion of disease prevalence was even
higher in egg-bearing female lobsters, where prevalence was reported at 60-80% (Castro
and Somers 2012). While ESD prevalence remains low in the Gulf of Maine, the mean
prevalence has more than doubled in the past 8 years from 0.5% to 1.2% (Reardon et al.
in press).
ESD is characterized by unsightly, melanized lesions that degrade the lobster’s
carapace. These lesions significantly decrease the lobster’s market value, and can lead
to negative impacts on lobster health, sometimes resulting in death (Smolowitz et al.
2005; Hoenig et al. 2017). Although the etiology of ESD is not well understood,
outbreaks are likely influenced by a number of factors including compromised condition
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of the host, presence of putative pathogens in the ecosystem, and environmental stress
(Tlusty et al. 2007; Gomez-Chiarri and Cobb 2012; Shields 2013, Barris et al. in press).
Comparative analysis of microbial communities between ESD-infected and healthy
lobsters suggest the disease is polymicrobial, and two species of bacteria, Thalassobius
sp. and Aquimarina macrocephali (formerly designated Aquimarina ‘homari’), may be
involved in the progression of ESD lesions (Chistoserdov et al. 2005; Quinn et al. 2012).
Additionally, there is evidence of a transition to lower bacterial diversity in and around
the lesions of laboratory-reared lobsters with shell disease, potentially initiated by
dysbiosis in the microbial community on the shell (Feinman et al. 2017).
While the decrease in lobster populations in southern New England is not solely
due to ESD, high rates of ESD have been linked to a decrease in overall larval supply
and subsequent population declines in Rhode Island (Wahle et al. 2009). It is
hypothesized that ESD triggers molting in lobsters as a defense mechanism, so lobsters
can get rid of the diseased shell before the disease negatively impacts the lobster (Laufer
et al. 2005). Consistent with this hypothesis, significantly high levels of the ecdysteroid
receptor (a gene associated with molting) have been reported in lobsters with ESD,
which may be triggering them to molt more frequently (Smolowitz et al. 2005; Castro
and Somers 2012; Tarrant et al. 2012). If ovigerous females molt too early in an effort
to rid themselves of the disease, this would result in the loss of their entire clutch of
eggs. Alternatively, lobsters can die from ESD if the lesions are so severe that ulceration
of the epidermis occurs and prevent the lobster from molting successfully (Smolowitz
et al. 2005). Mark-recapture studies on lobsters in the southern New England stock
estimate that lobsters with moderate to severe ESD have a survival rate of only 30%
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when compared to healthy lobsters (Hoenig et al. 2017). High mortality in diseased
lobsters, and especially in ovigerous females, could explain population declines and the
poor larval recruitment observed in southern New England (Hoenig et al. 2017).
Despite characterization of the bacterial community on ESD-associated lesions
(Meres et al. 2012; Feinman et al. 2017), Koch’s Postulates have not been fulfilled for
ESD (Gomez-Chiarri and Cobb 2012). Koch’s Postulates specify that in order to
identify the causative agent of an infectious disease, four criteria must be met: the
pathogen must be present in all cases of disease; the pathogen can be isolated from the
diseased host and grown in pure culture; the pure culture must cause disease when
inoculated into a new healthy host; and finally, the pathogen must be reisolated from
the new host and shown to be the same pathogen (Fredricks and Relman 1996). The
absence of a laboratory model that fulfills Koch’s Postulates makes ESD a particularly
difficult disease to study, and leaves those who rely on lobsters for their livelihood with
more questions than answers. Quinn and colleagues (2012) discovered that abrading the
epicuticle of lobsters and then exposing them to A. macrocephali alone, or a suite of A.
macrocephali, Thalassobius sp., and Pseudoalteromonas gracilis resulted in lesion
formation. However, non-abraded lobsters with the same treatments did not form
lesions, indicating that these bacteria may be opportunistically colonizing lesions and
furthering their development rather than initiating disease (Quinn et al. 2012).
Currently, there are no applied management tools for controlling or mitigating
ESD in wild lobster populations. Since transmission and onset of the disease is not
understood, typical disease mitigation strategies cannot be proven effective in the
southern New England system. When fishermen encounter a diseased lobster, they only
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have a few options: remove the lobster from the population; throw the lobster back in
the water after catching; or sell the lobster for processed meat at a significantly reduced
price. Additionally, lobsters lack an adaptive immune system that is characteristic of
vertebrates, rendering traditional vaccines aiding in disease prevention an unviable
option (Vazquez et al., 2009). We propose that probiotics could offer an alternative,
novel tool for disease management. Probiotics are naturally occurring microorganisms
that can provide health benefits to the host. While often thought of as food supplements,
probiotics can also be added to water for aquatic organisms. These microorganisms have
already shown disease protection in many other invertebrates and fish in aquaculture
farm settings (Verschuere et al. 2000; Karim et al., 2013; Wu et al., 2014; Zhao et al.,
2016; Safari and Paolucci, 2017).
Probiotic bacteria may confer benefits to the host in a number of ways, including
competition with pathogenic bacteria, or modulating the immune system of the host
(Perez-Sanchez et al. 2014; Zhao et al. 2016). These mechanisms of action can give
organisms an advantage when fighting disease (Newaj-Fyzul et al. 2014). Probiotics are
a favorable alternative to other treatments, like antibiotics, because probiotics do not
select for antibiotic-resistant bacteria. While the application of probiotics in a wild
fishery is more challenging than administration in an aquaculture farm, probiotics could
offer a promising approach for ESD treatment if they can be incorporated in currently
used lobster fishing practices.
Due to the high prevalence of ESD in southern New England and expansion
within the Maine lobster fishery, fishermen need tools to sustain the fishery long-term
and avoid economic consequences. Previous work in our collaborative, interdisciplinary
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probiotic group at the University of Rhode Island (URI) has identified 24 bacterial
strains from the shells of healthy-appearing lobsters in Narragansett Bay in 2016 that
exhibit probiotic characteristics (Underwood 2018). These strains were tested against
putative ESD pathogens, Thalassobius sp. and Aquimarina macrocephali, to identify
features characteristic of probiotic bacteria, including the ability to: 1) inhibit the growth
of putative ESD pathogens; 2) form strong biofilms; and 3) compete with putative
pathogens in co-incubation experiments (Zhao et al. 2016). Other criteria considered
when selecting probiotics included: 4) the ease in which the bacterial strains can be
cultured; 5) if the strain is safe to use on the host; 6) ability of the strain to enhance
physiological processes such as growth; or 7) ability of the strain to slow the progression
of disease (Perez-Sanchez et al. 2014).
Based on our understanding of how candidate probiotics isolated from lobsters
interacted with putative ESD pathogens in vitro (Underwood 2018), we tested the effect
of treatment with candidate bacterial strains on lobsters in vivo. This involved
examining the safety of candidate probiotic strains on post-larval lobsters and testing
the effect of selected candidate probiotics on the progression of ESD lesions in adult
lobsters. Determining the efficacy of probiotics in slowing or stopping the progression
of ESD can help establish probiotics as a potential disease mitigation tool for ESD, or
diseases similar to ESD.
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Methods
1) Bacterial Strains
Isolation, growth, and characterization of potential probiotics was conducted by
Grace Underwood and Hilary Ranson at the University of Rhode Island (Underwood
2018). These strains (Table 1) were cryogenically preserved for further characterization
and testing for in vivo trials. A probiotic isolate known to protect larval oysters against
challenge with bacterial pathogens, Phaeobacter inhibens S4 (Karim et al. 2013) was
included as control.

Table 1. Candidate probiotics used in this research.
ZOI (mm)

ZOI (mm) against

Isolate

16s Sequencing

against

Aquimarina

Biofilm

ID

Identification

Thalassobius sp.

macrocephali

(OD 580)

B*

Bacillus sp.

2

4.33

2.88

L210*

Loktanella maritima

2

0

3.71

L211

Loktanella maritima

1.7

0

3.71

P01

Pseudoalteromonas sp.

4.3

0

3.17

P11

Pseudoalteromonas sp.

0

2.2

3.32

P14*

Pseudoalteromonas sp.

2.5

0

3.24

P18

Pseudoalteromonas sp.

0

1.6

2.89

P21

Pseudoalteromonas sp.

1.17

0

2.18

P22

Pseudoalteromonas sp.

1.83

0

3.71

S4*

Phaeobacter inhibens

1

1.4

3.89

* Spontaneous streptomycin-resistant (Smr) strains were developed in previous research
and were used in PL Experiment 3 (Underwood 2018).
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Bacterial Growth Conditions
Bacterial species routinely grown included A. macrocephali I32.4, Thalassobius
sp. I31.1 (Chistoserdov et al. 2005), and the selected potential probiotic isolates (Table
1; Underwood 2018). If available, spontaneous streptomycin-resistant (Smr) strains
developed in previous research were used in PL experiment 3. This included: L.
maritima 06-YPC210 Smr, Pseudoalteromonas sp. 03-YP014 Smr, and Bacillus sp. 06YP001 Smr (Underwood 2018), and P. inhibens S4Smr (Zhao et al. 2016). Bacterial
isolates were grown at room temperature (23°C) on YP30IOS (10 g peptone, 2 g yeast,
60 g of Instant Ocean Salt™ and 30 g agar, dissolved in 1 L deionized water, pH 7.0;
with or without 100 µg/mL Sm depending on the isolate) agar plates or in YP30IOS
liquid media in 50 mL polypropylene culture tubes with shaking (150 rpm).

2) Post-larval (PL) lobster probiotics screening
In order to detect any adverse effects of the candidate probiotic bacterial strains
on survival and health, lobsters at the post-larval stage, a more vulnerable and easier to
handle life stage than adults, were exposed to candidate probiotics (Table 1). Three
experiments were performed, in which conditions to test the candidates were
progressively optimized.

PL Experiment 1
Developmental stage three and four lobster post-larvae (PL) were obtained from
the Mount Desert Oceanarium & Lobster Hatchery in Bar Harbor, Maine and brought
to the East Farm Fisheries Center at URI on September 14, 2016. Plastic 750 mL
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containers were filled with artificial seawater (ASW; 35 psu, 16°C) and 3 x 30 mL
medicine cups were secured in each of the 750 mL containers. Small holes had been
punched into the medicine cups using a syringe needle (25G) to ensure water flow and
one PL was placed in each medicine cup. PLs were left to acclimate for two days.
Four randomly assigned 750 mL containers were used for each treatment, for a
total of 12 PLs per treatment, 3 lobsters per container. There was one control group and
seven experimental treatment groups (B, L210, L211, P14, P21, P22, and S4; Table 1).
Experimental treatments were administered at a concentration of 104 colony forming
units (CFU) per mL of seawater via addition to their container by pipette (85-125 µL
per well, dependent on bacterial stock concentration), two days after acclimation began.
Five days later, any PLs that died were replaced with extra PLs and a second treatment
was administered. Twenty-four hours after the second probiotic treatment, all PLs were
exposed to putative pathogen, Thalassobius sp., at a concentration of 104 CFU/mL. PLs
were then left in their containers for another 15 days, for a total of 20 experimental days.
Each day, mortality (number of PLs dead), molting (number of PLs that molted), salinity
(psu), and temperature (°C) were monitored. PLs were fed frozen Artemia sp. (Sally's
Frozen Brine Shrimp™, San Francisco Bay Brand, Newark, CA) daily and debris was
removed from containers 1-2 hours after feeding. Water changes occurred every four
days, with half of the total volume in the 750 mL holding container being exchanged.
Temperature during this experiment was maintained at 16°C. At the end of the
experiment, photographs were taken of PLs.
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PL Experiment 2
Stage four and five PLs were obtained on March 30th, 2017 from the Sound
School, a vocational aquaculture high school in New Haven, Connecticut, and brought
to the Center for Marine Life Sciences at URI (Narragansett, RI). PLs were acclimated
in a fifteen-gallon aquarium tank with ASW (30 psu, 18°C) for 24 h, and were then
placed in six-well plates. Six-well plates were used instead of a shared container, like in
PL experiment 1, to limit effects PLs would have on each other and to increase statistical
power. Each well contained one PL and 10 mL of artificial seawater. PLs were left to
acclimate for three days. There were two 6-well plates per treatment, for a total of 12
PLs per treatment. There was one control group, which received no treatment, and 12
experimental treatment groups (Table 1). Full water changes were administered daily
using a serological pipette roughly 1 h after PLs were fed frozen Artemia sp. Lids were
removed from the 6-well plates to better promote oxygen transfer into the water and the
plates were held at room temperature (18-20°C).
Experimental treatments were administered at a concentration of 104 CFU/mL
via addition to their container by pipette (12-20 µL per container, dependent on bacterial
stock concentration) once a week for two weeks, with treatments starting on April 3,
2017. Each day, mortality (number of PLs dead), molting (number of PLs that molted),
salinity (psu), and temperature (°C) was monitored. The experiment was halted after
two weeks when cumulative mortality reached almost 70%. PLs were photographed at
the beginning and end of the experiment under a dissecting microscope to look for
lesion-like marking or spots using Lumenera Infinity-1 microscope camera and Infinity
Capture software (Lumenera Corporation, Ottowa, ON).
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PL Experiment 3
Experimental Design and husbandry
Stage seven and eight lobster post-larvae were obtained from the Sound School
(New Haven, CT), and transported to the Center for Marine Life Sciences at URI on
September 13, 2017. During transportation, PLs were held in ambient seawater from the
Sound School and an ice pack. Upon arrival, PLs were transferred into individual 250
mL glass culture dishes (Carolina Biological Supply Co., Burlington, NC) with seawater
(29-31 psu salinity) from Narragansett Bay filtered through 2µm pore-size filter and
kept between 14-18°C. The containers were kept in a water bath at (target temperature
of 16°C) to maintain temperature stability. All containers were wrapped in black
electrical tape so that PLs would not be able to see each other in order to reduce potential
stress due to their aggressive behavior. Containers were randomly assigned a candidate
probiotic and a unique identifier, with ten PLs per treatment. There were six different
experimental treatments treatment (BSmr, L210Smr, L211, P14Smr, and S4Smr, and
AT, a mix of A. macrocephali, or Thalassobius sp.; Table 1) and one control group
which received no treatment. PLs acclimatized in the lab for seven days were
photographed under a dissecting microscope (15x magnification) using a Lumenera
Infinity-1 microscope camera. Images were used to measure PL size using Infinity
Capture imaging software and count lesion-like markings or spots on their shell.
Additional pictures were taken of all PLs (including dead) on days 25 and 40 of the
experiment.
On day 1, PLs were exposed to their designated probiotic treatment at a
concentration of 104 CFU/mL of seawater via addition to their container by pipette (150-
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250 µL per container, dependent on bacterial stock concentration). PLs were exposed
to their treatment for 24 h, at which point water was partially changed (150 out of 250
mL of seawater). PLs were treated once a week for 25 days and then twice a week for
an additional 15 days. One day before treatments were administered, PLs were given a
full (250 mL) water change. Mortality and molting occurrence were recorded daily. PLs
were fed daily with frozen Artemia sp. Water in the holding containers was partially
changed each day about 1 h after feeding, with 150 of 250 mL (16°C, 29-31 psu salinity)
seawater being exchanged, so that excess food was removed. Before water changes,
three randomly selected PL containers were chosen each day for testing of the following
water quality parameters: ammonia (ppm), nitrate (ppm), and pH using the API
Saltwater Master Test Kit (Mars Fishcare North America, Inc.), dissolved oxygen (DO,
mg/L) using a Milwaukee MW600 portable DO meter (Milwaukee Instruments, Rocky
Mount, NC), and salinity (psu) using a refractometer. Temperature loggers (HOBO,
Water Temp Pro v2, Onset Computer Corporation, Bourne, MA) were deployed in the
water baths to record ambient water temperature every 10 min. Additionally, dissolved
ammonium levels (µmol) were measured in all experimental containers on day 35 after
the start of treatments (two days after a probiotic treatment) and on day 40 (4 days after
a probiotic treatment). Dissolved ammonium concentration was measured using
standard colorimetric techniques (Solorzano 1969) in an Orion Aquamate 7000 VIS
Spectrophotometer©. Dissolved oxygen was also measured at the end of the experiment
(day 40). Surviving PLs were photographed and stored in 30 mL 95% ethanol.
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Bacterial Sampling and Evaluation of Colony Forming Units (CFU):
Samples of water and biofilm on the surfaces of the incubation containers from
Experiment 3 were collected from the PL containers to: 1) determine the ability of
probiotics to persist after treatment; and 2) investigate effect of probiotic treatment on
bacterial load. This sampling was performed only for streptomycin-resistant isolates
(Table 1), to allow us to differentiate between probiotic counts (determined on Sm
media) versus total bacterial counts in the containers (determined on media without Sm).
Water and biofilm samples were taken immediately after probiotics were administered
(day 0) and on days 1, 3, and 6 after probiotics treatment during the first week of the
experiment, from 3 randomly selected containers. Biofilm samples from all containers
were also taken on the last day of the experiment (day 40, Table 2). For water samples,
approximately 1.5 mL of water was removed from PL holding containers and placed in
a micro centrifuge tube. For the first four collection time points, three samples were
taken from each treatment. For biofilm samples, a sterile polyester-tipped applicator
was used to swab the entire circumference of PL containers. The applicator was then
vigorously stirred in 1 mL of ASW for 20 seconds. Serial 1:10 dilutions up to 10-6 were
performed for each sample, and all dilutions were spot plated in triplicate (10 µL/spot)
on to YP30 agar plates (to measure total bacterial load) and onto YP30Sm agar with
antibiotic (streptomycin, 200µg/mL). The plates were incubated at room temperature
(18-20°C) for at least 2 days or until colonies formed. After incubation, all colonies
were counted, counts for each dilution were averaged, and the average CFU/mL was
calculated for each treatment. The morphology of colonies on YP30Sm plates was
evaluated to confirm it corresponded to the candidate probiotic.
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Table 2. Sampling timeline for water and swab samples for determination of bacterial
concentrations (CFU/mL). Sampling started before probiotic treatments started (day 0),
and ended after 40 days when the experiment was terminated. All water and swab
samples were collected as described in the methods for every time point.
CFU Sampling Timeline
Date, Time
# Day
Number of
containers
sampled for SmR
bacterial
concentrations in
water
Number of
containers
sampled for total
bacterial
concentrations in
water
Number of
containers
sampled for SmR
bacterial
concentrations in
surfaces
Number of
containers
sampled for total
bacterial
concentrations in
surfaces
Treatments
Sampled

9/21/17,
7:00am

9/21/17,
5:00pm

9/22/17,
4:00pm

9/24/17,
4:00pm

9/27/17,
4:30pm

-

0

1

3

6

40

3

3

3

3

3

0

3

0

1

3

1

0

0

0

3

0

3

[Control, BSmR,
S4SmR, L211, AT] = 7

11/1/17, 9:00am

P14SmR = 6
L210SmR = 5
0

0
1
0
1
Control, BSmR, S4SmR, P14SmR, L210SmR

Control, BSmR, S4SmR,
P14SmR, L210SmR

3) Diseased Adult Lobster Probiotic Testing
In order to test the ability of the candidate probiotics to slow ESD progression,
one laboratory trial was run with sublegal-sized lobsters from Narragansett Bay, RI with
ESD. Lobsters averaged 82.5 mm (± 2.1 mm SD) carapace length and included 34 males
and 6 females. Lobstermen from the RI Lobstermen’s Association collected the adult
lobsters for this trial from outside of Fort Wetherill in Narragansett Bay. Lobsters were
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transported to the Graduate School of Oceanography at URI in the Center for Marine
Life Sciences, where each was placed in an individual 57 L tank with flowing seawater
(roughly 300-500 mL/min) from Narragansett Bay, RI and maintained at a temperature
of 16°C and 29-31 psu salinity. The trial took place starting in October of 2016 and
ending in January of 2017, since this is typically after lobsters have molted and ESD
condition was expected to be less severe (Castro and Somers 2012).
Candidate probiotics for treatments were selected based on a combination of the
in vitro data (Underwood 2018) and performance in PL screening experiments as
determined. The following criteria were used in the selection process: ease in which the
candidate probiotic isolate can be cultured in the lab; ability to inhibit the growth of
pathogens (ZOI) and form biofilms; and lack of toxicity or potential decrease in
mortality of PLs during exposure experiments as compared to non-treated PLs.
Experimental treatments included one control group which received no treatment (n =
10 lobsters) and three experimental groups each tested with either B, P14, or S4 (Table
1, n = 10 lobsters per treatment). Tanks were assigned to treatments randomly. Prior to
treatment, water flow to the tanks was halted (15 min) to ensure adequate residence time
for the probiotic treatments. Probiotics were added to lobster tanks twice a week at a
concentration of 104 CFU/mL, and left to incubate in their tanks for 15 minutes, at which
point water flow was resumed.
Mortality (number of dead individuals), molting (number of individuals that
molted), and tank water salinity (psu) and temperature (°C) were measured at least 3
times a week. Lobsters were photographed (using Olympus Stylus TG-4 camera) and
measured at the beginning and end of the trial to document and analyze changes in
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percent cover of lesions on the lobsters over time. The camera was placed at a fixed
distance for photographs and 7 pictures were taken for each lobster at the beginning and
end (dorsal carapace, right lateral carapace, left lateral carapace, dorsal abdomen, right
lateral abdomen, left lateral abdomen, dorsal claws).

Data Analysis
Survival and molting occurrence curves were analyzed using Prism 6.0
(GraphPad Software, La Jolla, CA) to determine differences in mortality across
treatments over time using a Log-rank Mantel-Cox statistical test.

For molting

occurrence curves, PLs that died during the experiment were censored. Growth (change
in carapace length from start to end of experiment) was analyzed using a one-way
ANOVA in R Studio. The proportion of PLs with lesions in each treatment was
determined and analyzed using a chi-square test in R Studio. The effect of treatment on
changes in the amount of bacteria (CFU/mL) in water and biofilm samples over time
was analyzed using a two-way ANOVA with pairwise multiple comparison post-hoc
test (Tukey) in Prism 6.
For the adult lobster trial, the percent change in lesion cover was measured for
each lobster and placed in a binary category of ESD condition being “severe” or “not
severe.” When an individual had more than 50% of their body covered in lesions, they
were characterized as having severe ESD (Tarrant et al. 2012). A series of chi-square
tests were run in R Studio to investigate if mortality, molting, or disease severity differ
significantly based on treatment.
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Results
PL Experiment 1
Over the course of the 20-day experiment, there were no significant differences
in survival or molting occurrence between treatments (Fig. 1). At the end of the
experiment, pinpoint, circular melanized lesion-like markings on the lobster’s shells
were observed (Figs. 2, 3). While there were no significant differences between
treatments, the proportion of PLs with lesions was higher in the L210 treatment (Fig.
2). Since lobster appearance was not documented at the beginning of the experiment, it
is uncertain whether these lesions developed during the experiment as an effect of
treatment. The addition of Thalassobius sp. on day 6 of the experiment did not have an
effect on PLs survival, molting or presence of lesions.
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Figure 1. Effect of candidate probiotic treatment on percent survival and percent
molting occurrence of lobster post-larvae (PL) over 20 days during Experiment 1. At
time 0, probiotics were administered to PLs and one day later they were challenged with
Thalassobius sp. No significant differences in survival or molting between treatments
were observed (survival Log-rank test p=0.42, molting Log-rank test p=0.74).
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Figure 2. Effect of candidate probiotic treatment on mean proportion of lobster postlarvae with lesions after 15 days during PL Experiment 1. Averages were taken from
the proportion of lobsters in each treatment (3 per beaker, 4 replicates) with lesions. No
statistical differences were observed between groups (chi-square p=0.43).

Figure 3. Photograph of a representative lobster post-larvae with potential shell
disease lesions. This PL was treated with probiotic candidate Bacillus sp. for 20 days
in PL Experiment 1.
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PL Experiment 2
This experiment was terminated 15 days after start of treatment due to heavy
mortality (69% of all PLs died). Significant differences in survival were observed
between control and L210 treatments, which showed the highest mortality (Log-rank
test p=<0.0001, Fig. 4). Water temperature during this experiment ranged from 1920°C. At this time point, percent survival was lowest in the control and L210 (0 and
8.3% survival, respectively) treatments when compared with the rest of the treatments
(ranging from 25-75% survival). There were no significant differences in molting
between treatments (Fig. 4), and lesions were not observed on PLs at either the start or
end of the experiment.
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Figure 4. Effect of candidate probiotic treatment on percent survival (top) and percent
molting occurrence (bottom) of lobster post-larvae over 14 days during PL Experiment
2. At time 0, probiotics were administered to PLs. Significantly higher mortality was
observed in the L210 and control treatments (Survival Log-rank test p=<0.0001,
Molting Log-rank test p=0.10) than in other treatments. Asterisks denote the level of
significance (p-value) when compared to the control.
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PL Experiment 3
Survival, Molting, Growth, and Lesions:
Throughout the 40-day experiment there were no significant differences in
survival between treatments (Fig. 5). Cumulative mortality levels remained below 50%
in all of the treatments. Treatment with a mix of A. macrocephali and Thalassobius sp.,
(AT) did not have a significant effect on PLs compared to other treatments, including
the control. On day 34 of the experiment there was a mortality event where 12 PLs died
(0-30% mortality in each treatment) (Fig. 5). There was no significant difference in
molting occurrence between treatments (Fig. 5). There were also no significant
differences in growth of the lobsters that molted and survived the entire experiment (Fig.
6). Two individuals from different treatments (L211 and P14Smr) developed lesions
during the experiment (Fig. 7), and both died (on days 26 and 33, respectively).

Water Quality Parameters:
Average temperature ranged from 14-18°C and salinity ranged from 30-33 psu
during the 40-day experiment (Fig. 8). Temperature fluctuations were a result of the
water cooling system at the Center for Marine Life Science and changes in temperature
in the source water from Narragansett Bay. Fluctuations were also observed in dissolved
oxygen, nitrate, and pH, with ideal water quality parameters being observed after full
water changes. Nitrate concentrations remained low until day 31, after which nitrate
concentrations periodically spiked until the end of the experiment (Fig. 18). There were
no significant differences between treatments in ammonium or dissolved oxygen
measurements taken at the end of the experiment (Figs. 9, 10).
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Effect of probiotic on bacterial levels:
Significantly higher levels of some of the candidate probiotics could be detected
in samples of water (as determined by counts of streptomycin resistant bacteria) from
the PL containers on day 0 (right after the probiotic treatment was administered; S4Smr
and BSmr was significantly higher than P14Smr) and day 1 (24 hours after treatment;
S4 was significantly higher than all treatments) (Two-way ANOVA, p=<0.05; Fig. 11
and Table 4). Significant differences in probiotic concentration between treatments on
day 0, right after addition of candidate probiotics to the containers, were probably due
to differences in the relationship between CFU and OD580 (the parameter used to
estimate bacterial concentration in the stocks) between candidate probiotic isolates.
There was a significant interaction between time and probiotic concentration (Two-way
ANOVA, p=<0.05; Table 4). By day 3 and 6 (after full water changes in PL containers
occurred) there was no statistical difference between treatments, but Smr bacteria could
be detected at low levels in water samples from all treatments, including the control, on
day 6 (Fig. 11).
Neither treatment nor time had a significant effect on probiotic bacterial
concentration on the water-immersed surfaces of PL containers (Two-way ANOVA
effect of treatment p=0.07, time p=0.09, time x treatment interaction p=0.12; Fig. 12
and Table 6). Post-hoc pair-wise comparisons of treatments within day 1 (24 hours after
treatments were administered), however, showed that S4Smr had a significantly higher
biofilm concentration (1.64x105 CFU/ml) when compared with BSmr (2.67x104
CFU/ml) (Two-way ANOVA, p=<0.05, Tables 5 and 6). By days 6 and 40, there was
no statistical difference between treatments, but Smr bacteria could still be detected at
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low levels in water samples from all treatments, including the control (Fig. 12, Tables
5 and 6). Colony morphologies of the control samples were variable between different
PL containers and the day they were sampled.
Treatment did not have a significant effect on total bacterial load (as measured
on YP30 agar plates) in water samples 3 days after probiotics were administered (Oneway ANOVA p=0.34; Fig. 13) or in biofilm samples taken from PL container surfaces
on day 40 (One-way ANOVA p=0.10; Fig. 14).
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Figure 5. Effect of candidate probiotic treatment on percent survival and percent
molting occurrence of lobster post-larvae over the course of the 40-day experiment
during PL Experiment 3 (Log-rank Mantel-Cox test for survival p=0.98, and for molting
p=0.42).
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Figure 6. Effect of candidate probiotic treatment on average growth (mm) of lobster
post-larvae that both molted and survived throughout PL Experiment 3. (One-way
ANOVA p=0.17). Large black dots represent the mean, boxes represent upper and lower
quartile, black line within the box represents the median, and whiskers indicate
minimum and maximum values.

Figure 7. Photographs of lobster post-larvae that developed lesions in PL Experiment
3. These individuals were from the L211 (left) and P14 treatment (right). Both
individuals died before the end of the experiment on days 26 and 33, respectively.
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Figure 8. Representative water quality conditions in lobster post-larvae dishes during
PL Experiment 3. Each day, three PL dishes were chosen at random to test water quality
parameters.
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Figure 9. Effect of candidate probiotic treatment on ammonium levels (µM) at two time
points at the end of experiment during PL Experiment 3. The top figure is from samples
taken on day 35 of the experiment, 2 days after probiotic treatment. The bottom figure
is from samples on day 40 of the experiment, 4 days after probiotic treatment (One-way
ANOVA for day 35, p=0.60; One-way ANOVA for day 40, p=0.19). Large black dots
represent the mean, boxes represent upper and lower quartile, black line within the box
represents the median, and whiskers indicate minimum and maximum values.
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Figure 10. Effect of candidate probiotic treatment on dissolved oxygen (mg/L) in
lobster post-larvae dishes on the last day of the experiment during PL Experiment 3.
DO was recorded on day 40 of the experiment, 4 days after a probiotic treatment.
Sample sizes ranged from 5-7 containers (One-way ANOVA p=0.10). Large black dots
represent the mean, boxes represent upper and lower quartile, black line within the box
represents the median, and whiskers indicate minimum and maximum values.
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Figure 11. Effect of candidate probiotic treatment on average SmR bacterial
concentration (CFU/mL, as determined on YP30Sm plates) from the water in lobster
post-larvae dishes during the first week of PL Experiment 3. Error bars represent
standard error. There were significant differences between treatments on day 0 and 1
(Two-way ANOVA p=<0.0001).
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Figure 12. Effect of candidate probiotic treatment on average SmR concentration
(CFU/mL, as determined on YP30Sm plates) on the surface of containers for PL
Experiment 3. Error bars represent standard error. There were no significant differences
between treatments over time (Two-way ANOVA p=<0.09), except on day 1, B was
significantly lower than S4.
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Figure 13. Effect of candidate probiotic treatment on average total bacterial
concentration (in CFU/mL, YP30 media) from water samples collected from lobster
post-larvae containers 3 days after probiotics were added for PL Experiment 3. Levels
of SmR bacteria, as detected on YP30Sm agar plates, were subtracted from each of the
treatments. Error bars show standard error and there were no significant differences
between treatments (One-way ANOVA p=0.40).
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Figure 14. Effect of candidate probiotic treatment on average total bacterial
concentration (in CFU/mL, YP30 media) from biofilm samples collected from the
surfaces of lobster post-larvae containers on day 40 of PL Experiment 3. Levels of SmR
bacteria, as detected on YP30Sm agar plates, were subtracted from treatments. Error
bars show standard error (One-way ANOVA p=0.55).
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Adult Lobster Experiment
Due to the high prevalence of ESD in RI (Castro and Somers, 2012) most (about
50%) of the lobsters collected had moderate ESD at the start of the experiment, with
lesions affecting roughly 20-60% of the carapace surface. Mortality throughout the
experiment was very low, with only 2 individuals dying in total, one of which died on
the last day of the experiment. In both cases, mortality resulted from an unsuccessful
molt most likely induced due to the severity of ESD lesions. Throughout the experiment,
27 of the 40 lobsters molted, and no statistically significant differences between
treatments were detected (Log-rank test p=0.69; Fig. 15). Molting showed a significant
interaction with disease severity (Chi-square p= 0.00059), indicating this was the main
factor associated with molting, rather than treatment (Fig. 16). The number of lobsters
characterized as having severe ESD at the beginning of the experiment was 5-6
individuals per treatment (out of a total of 10). At the end of the experiment or time of
molt (whichever came first), the severity of ESD either stayed the same or worsened for
all individuals (Fig. 17). For lobsters that did molt, there was no significant difference
in growth between treatments (One-way ANOVA p=0.82; Fig. 18). None of the
treatments had a visible impact on lesion severity; however, no individuals displayed
signs of ESD again after molting.
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Figure 15. Effect of candidate probiotic treatment on percent molting occurrence of
adult lobsters over 16 weeks. No statistical differences in molting were observed
between treatments (Log-rank test p=0.69, Prism 6).

Figure 16. Relationship between molting occurrence and ESD severity for adult
lobsters over 16 weeks. “High Severity” indicates lesions covered >50% of carapace.
There was a significant relationship between severity of ESD and molting occurrence
(Chi-square p= 0.00059, R Studio).
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End of Experiment

Beginning of Experiment

Figure 17. Effect of candidate probiotic treatment on progression of ESD from
beginning to end of the adult lobster experiment. Individuals in each treatment were
characterized as “high” or “low” severity at the beginning and end of the experiment (or
at the time the lobster molted). “High Severity” indicates lesions covered >50% of
carapace. There were no significant differences between treatments and ESD worsened
for all treatments (Beginning of experiment Chi square p=0.93, End of experiment Chi
square p=0.81).
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Figure 18. Effect of probiotic treatment on growth (mm) of lobsters that molted during
the adult lobster experiment. There were no statistical differences in growth between
treatments (One-way ANOVA p=0.82). Boxes represent upper and lower quartile, black
line within the box represents the median, and whiskers indicate minimum and
maximum values.
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Discussion
The aim of this research was to 1) develop methods for in vivo screening of
candidate probiotics against ESD in American lobsters; and 2) test the effect of these
candidate probiotics on the progression of ESD in adult lobsters. Three different PL
screening assays were performed to determine the best method for rapid screening of
several candidate probiotics on live lobsters. While probiotic screenings have been
conducted in other juvenile crustacean species for disease control applications, such as
the spiny lobster, Panulirus ornatus, (Nguyen et al. 2014), crayfish (Safari and Paolucci
2017), and various shrimp species (Hai and Fotedar 2010; Kumar et al. 2016), these
experiments have never been conducted for Homarus americanus in the context of ESD.
Based on these screening experiments, several potential probiotics were selected for
testing on adult lobsters with ESD. We found that: 1) potential probiotic isolates did not
have adverse effects on lobsters at the post-larval (PL) stage; 2) several of the probiotic
candidates may protect lobster PL from environmental stress; 3) there were no visual
improvements to ESD lesions in an experiment performed with adult lobsters that had
moderate to severe ESD before treatment.
Our collaborative probiotic group at URI was able to select, identify, and test
seven different candidate probiotic strains that were isolated from lobsters. One of these
strains, P. inhibens S4, was isolated from the eastern oyster, Crassostrea virginica, and
has proven disease protection in the larvae of hatchery-reared oysters (Karim et al.
2013).

Each of the candidate probiotics displayed growth inhibition against A.

macrocephali and/or Thalassobius sp., two putative ESD pathogens isolated from
lobsters with lesions (Chistoserdov et al. 2005). The role of these putative pathogens in
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ESD progression, however, is not clear (Meres et al. 2012; Quinn et al. 2012; Feinman
et al. 2017), and this is a limitation for the selection of possible probionts. Our
assumption was that the antibiotic activity against these ESD-associated bacteria,
combined with the ability to form strong biofilms on lobster shells, would indicate the
likelihood of being protective against ESD.
Screening probiotic isolates on PLs allowed for pre-selection of the candidate
probiotics with the highest potential for probiotic activity to be tested in labor-intensive
adult lobster trials, and could be used as a model for future probiotic discovery strategy.
We encountered several challenges in the development of screening protocols using
lobster PLs, based on the need to keep PLs in individual containers due to their
cannibalistic nature. In PL experiment 1, the design allowed for maintenance of water
quality, but did not allow for high statistical power since three PLs were in each
container. This concern was addressed in PL experiment 2 where PLs were kept in
separate wells of 6-well plates, but the water temperatures that reached 20°C, which is
known to be stressful to juvenile and larval lobsters (Waller et al. 2016), was likely
detrimental to PL survival. The small volume of seawater in 6-well plates also could
have led to poor water quality conditions such as low dissolved oxygen and high
ammonia. In PL experiment 3, PLs were kept in larger glass bowls with frequent water
changes and kept at a relatively constant temperature. This method was the most
successful in providing a static system yet keeping physiological stress low as measured
by mortality.
Despite differences in experimental design, we can use consistent findings from
all three PL screening experiments to infer the effect of treatment of potential probiotics
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on lobsters at a vulnerable, early life stage. The PL screening assays indicated that most
of the candidate probiotic treatments did not have statistically significant toxic effects
on individuals. Survival was low in PL experiment 2, likely due to adverse
environmental conditions, most probably temperature stress. Interestingly, several of
the probiotic isolates significantly enhanced PL survival as compared to the control
group in these conditions. In larviculture of the blue swimming crab, Portunus
pelagicus, a probiotic water additive was shown to be effective at improving water
quality and enhancing survival when challenged with a pathogen (Dad Talpur et al.
2013).

An effect of treatment on water quality parameters (dissolved oxygen,

ammonium), however, was not seen in PL experiment 3. Further research is needed to
confirm the ability of candidate probiotic treatment to increase PL survival under
conditions of environmental stress, as well as determine the mechanisms involved in
this protection. These could include, for example, the potential of probiotics to influence
water quality parameters such as nitrate, ammonia, and pH or to protect PLs against
opportunistic infections triggered by stressful conditions (Verschuere et al. 2000; Hai
and Fotedar 2010; Dad Talpur et al. 2013).
Molting occurrence was not influenced by treatment in any of the experiments
conducted in this study. Subsequently, probiotic treatments did not have significant
effects on growth of lobsters that did molt during the experiments. This finding is
inconsistent with evidence of enhanced growth from certain probiotic dietary
application in Homarus gammarus larvae (Daniels et al. 2010) and Panaeus monodon
(Boonthai et al. 2011), and with probiotic water additive application in freshwater
crayfish (Dash et al. 2016). However, Middlemiss and colleagues (2015) found that
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adding Bacillus sp. to the water of larval and post-larval H. gammarus had no significant
impacts on growth or weight (Middlemiss et al. 2015). In the future, larger sample sizes
and longer trials could help more rigorously determine treatment impacts of probiotics
on growth.
Combined evidence from these experiments indicated that Loktanella maritima
L210 should not be further considered as a probiotic candidate. This evidence included
the higher (although not significant) incidence of lesions on PLs in experiment 1 and
the fact that L210 was the only strain that did not show protective effects on survival
under severe environmental stress in experiment 2. Additionally, bacteria from the
genus Loktanella have been observed in cultures from ESD lesions and have been
observed around lesions of laboratory-reared lobsters (Feinman et al. 2017)
The goal of measuring bacterial concentrations in water and biofilm samples
from PL containers in experiment 3 was to determine if the candidate probiotics persist
in the water, form biofilms on the PLs’ containers, and/or impact overall bacterial load.
Of the six bacterial treatments tested in this trial, four of them were streptomycinresistant strains, which allowed measurement of their concentration by plating onto Sminoculated YP30 media. This experiment had several limitations that should be
considered when interpreting the data. Contrary to expectations, colonies were present
on YP30Sm plates from water samples collected from control (no probiotic treatment)
containers on day 6 and biofilm samples collected on all days. There are some potential
explanations for this observation: a) the presence of streptomycin resistant
bacteria naturally occurring in the experimental system; b) contamination of some
control containers with probiotic treatments due to spray or experimental errors on
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delivering treatments; and/or c) contamination of the media used in sample
dilution prior to spot plating. In order to distinguish between these potential
explanations, colony appearance was also considered when counting colonies. Colony
morphology of the biofilm control samples were variable between days and containers,
indicating that it is unlikely that the media used for serial dilutions was contaminated,
since the same media was used for water samples, which showed no streptomycin
resistant bacterial growth from most control samples. Based on the data available, it is
not possible to distinguish between the other two alternatives, but further work would
be required to identify the colonies present on the plates. Another caveat of the
experiment was variation in probiotic concentrations between treatments when added to
PL containers, likely due to the inaccuracy of optical density measurements for
determining of bacterial concentrations, which prevented accurate estimation of
differences in bacterial loads between treatments. This variability could also be due to
artifacts in the sampling (e.g. probiotic isolates were not homogenously distributed in
the containers before bacterial sampling).
Despite these caveats, significantly higher levels of S4 and B were observed in
water from the containers one day after treatment as compared to control treatments,
suggesting that these strains can persist in the system for at least one day after treatment.
Interestingly, although B showed comparable levels to S4 in water on day 1 after initial
treatment, the containers treated with S4 showed significantly higher levels of bacteria
in the glass surfaces than B. This is consistent with in vitro data showing that S4 is a
stronger biofilm former than B (Underwood 2018) and previous research showing that
biofilm formation contributes to the probiotic ability of S4 in larval oysters (Zhao et al.
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2016). P. inhibens S4 and other isolates from the Roseobacter clade, have been shown
to protect various aquatic animals from disease (D ’alvise et al. 2012; Karim et al. 2013;
Prol García et al. 2014). Despite being an oyster bacterial isolate, S4 was one of the
only strains that showed a zone of inhibition against both lobster putative pathogens, A.
macrocephali and Thalassobius sp. These results, in conjunction with existing evidence
of S4 protection against disease in oysters (Karim et al. 2013; Zhao et al. 2016) warrant
further study of this particular isolate.
Probiotics had no measurable effect on overall bacterial load in the PL
containers, as measured by CFU/mL. Conserved 16S ribosomal RNA sequencing, an
approach commonly used to characterize microbiomes (Quinn et al. 2012; Closek et al.
2014; Arfken et al. 2017), of water and biofilm samples during PL assays could better
elucidate how the microbial communities change over time and between treatments.
Sequencing and quantification of bacteria through qPCR would also give a more
accurate representation of how the candidate probiotics persist in the water. Further
experiments looking at biofilm formation of candidate probiotics on lobster shells
should be performed. Examining the success of probiotic colonization on shells could
help us understand how successful probiotics could be competing with putative
pathogens in ESD lesions (Verschuere et al. 2000; Zhao et al. 2016).
Based on the results from the PL screening assays and the results from the in
vitro testing of antimicrobial activity and the ability of form biofilms, we decided to test
S4, B, and P14 on adult lobsters that had ESD. After 3 months of treatments performed
twice a week, the probiotics did not have a measureable effect on halting ESD
progression. Our results were confounded by the fact that most lobsters molted at
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different points throughout the experiment, making long-term tracking of ESD
progression challenging. It was surprising that so many lobsters molted, considering the
time of year (October-January) is not during the normal molting period for Rhode Island
lobsters (Castro and Angell 2000; Castro and Somers 2012). Our experiments show that
molting was related to the severity of ESD lesions, a result consistent with previous
observations that molting behavior is altered in ESD lobsters, and may be a strategy
used by lobsters to prevent the development of systemic infections (Smolowitz et al.
2005; Castro et al. 2006). It is also possible that the disease was too severe for the
candidate probiotics to have any sort of therapeutic effect, or for us to detect an effect.
Carapace erosions cannot be repaired, so if shell cuticles were already damaged, it
would be difficult to measure improvements in progression of the disease. Additionally,
bacterial communities in the lesions may have been too established and persistent for
probiotics to be effective. Considering the lack of an experimental model of ESD in
which the disease can be induced after treatment with candidate probiotics, lobsters with
beginning stages of ESD should be used in the future to more effectively track disease
progression. Different types of probiotic treatment delivery should also be considered,
such as the filters saturated with candidate bacteria used in a study investigating the role
of putative pathogens in lesion development (Quinn et al. 2012).
It may also be important to consider the probiotic isolates in this study in the
context of other H. americanus diseases, or other crustacean diseases in general – in
both fishery and aquaculture settings. For example, probiotics could be tested against
H. americanus diseases with a better laboratory model, such as the bacterial Vibrio
fluvalis infection (Beale et al. 2008) or Gaffkemia (Clark et al. 2013). Given the
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importance of crustacean fisheries and aquaculture for global protein sources (BondadReantaso et al. 2012), it is imperative to better understand their diseases and how to
manage them.
Investigating the use of probiotic treatments in a wild fishery has not yet been
researched to our knowledge. Implementing such technology is challenging,
considering the scope of the disease in southern New England lobster populations
(Hoenig et al. 2017), and that the etiology of ESD is not well understood. The current
body of literature for probiotic treatments in diseased marine organisms generally
applies to hatchery-based aquaculture systems rather than wild marine populations.
More research must be done in order to make recommendations about how to best apply
probiotics to the lobster fishery, or if probiotics will even be a viable option. Our goal
was to investigate the use of probiotic treatments by placing diseased lobsters in a
“probiotic bath.” Lobstermen in RI expressed that they would be willing to keep a
reasonably-sized probiotic bath on their fishing vessel, place diseased lobsters in this
bath for a pre-determined amount of time, and then return lobsters back into the ocean.
Our experiments were designed and conducted with this application model in mind, and
we explored various probiotic screening methods to try and determine which candidate
probiotic would be best-suited for application in the fishery.
The current application of probiotics in this study did not prove to be effective
in slowing or stopping the progression of ESD. However, we have developed a model
for screening candidate probiotics on PLs. An adult lobster experiment such as that
described here can verify if candidates chosen from screening assays are effective.
Further research determining the ability of probiotic isolates to form biofilms on lobster
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carapaces may help inform application in this context. Experiments examining biofilm
formation on sterile fragments of lobster shell (Underwood 2018) could also be used as
an effective screening tool, and could potentially be used instead of using live PLs.
Focusing on microbe-microbe interactions in future experiments will not only help us
better understand the probiotics mechanism of action, but could also provide more
information about how the bacteria from ESD lesions interact with potentially beneficial
bacteria.
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Additional Tables
Table 3. Effect of candidate probiotic treatment on average SmR bacterial concentration
(CFU/mL, as determined on YP30Sm plates) in water from lobster post-larvae dishes
during the first week of PL Experiment 3.

Table 4. Two-way ANOVA showing effect of probiotic treatment on average SmR
bacterial concentration (CFU/mL, as determined on SmYP30 plates) in water from
lobster post-larvae dishes during the first week of PL Experiment 3 (Prism 6).

Probiotic Concentration in Water
Two-way ANOVA
Interaction
Time
Treatment

P-value
0.0008
0.0004
< 0.0001

Significant?
Yes
Yes
Yes

Summary
***
***
****

Day 0
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4

<0.05
>0.05
>0.05
<0.05

Yes
No
No
Yes

*
ns
ns
****

B vs. L210
B vs. P14

>0.05
<0.05

No
Yes

ns
*

B vs. S4
L210 vs. P14

>0.05
>0.05

No
No

ns
ns

L210 vs. S4
P14 vs. S4

<0.05
<0.05

Yes
Yes

**
***

No
No
No
Yes
No
No

ns
ns
ns
****
ns
ns

Day 1
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14

>0.05
>0.05
>0.05
<0.05
>0.05
>0.05
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B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

<0.05
>0.05
<0.05
<0.05

Yes
No
Yes
Yes

***
ns
**
*

No
No
No
No
No
No
No
No
No
No

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns

No
No
No
No
No
No
No
No
No
No

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns

Day 3
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
Day 6

Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
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Table 5. Effect of candidate probiotic treatment on average SmR concentration
(CFU/mL, as determined on YP30Sm plates) on the surface of containers for PL
Experiment 3.

Table 6. Two-way ANOVA showing effect of probiotic treatment on average SmR
concentration (CFU/mL, as determined on YP30Sm plates) on the surface of
containers for PL Experiment 3 (Prism 6).

Probiotic Concentration in Water
Two-way ANOVA
Interaction
Time
Treatment

P-value
0.1236
0.0699
0.0864

Significant?
No
No
No

Summary
ns
ns
ns

Day 0
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
<0.05

No
No
No
No
No
No
Yes

ns
ns
ns
ns
ns
ns
*

L210 vs. P14
L210 vs. S4

>0.05
>0.05

No
No

ns
ns

P14 vs. S4

>0.05

No

ns

No
No
No
No
No
No
No
No
No
No

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns

Day 1
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
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Day 3
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05

No
No
No
No
No
No
No
No
No
No

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns

No
No
No
No
No
No
No
No
No
No

ns
ns
ns
ns
ns
ns
ns
ns
ns
ns

Day 6
Control vs. B
Control vs. L210
Control vs. P14
Control vs. S4
B vs. L210
B vs. P14
B vs. S4
L210 vs. P14
L210 vs. S4
P14 vs. S4

>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
>0.05
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